SEC Form 4 · accession 0001104659-17-018127
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason B. Shandell
Officer — President and General Counsel · Director
Period of report
Mar 16, 2017
Accepted (ET)
Mar 20, 2017 · 8:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 16, 2017 | A | 63,670 | $0.00 | A | 266,871 | D | |
| Common StockF3 | Mar 17, 2017 | F | 7,049 | $13.75 | D | 259,822 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $13.35 | Mar 16, 2017 | A | 158,784 | A | — | Mar 16, 2027 | Common Stock | 158,784 | 158,784 | D |
Explanation of responses
- F1The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 16, 2018.
- F2Includes 240 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2016.
- F3The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.
- F4Shares subject to the option vest in four equal annual installments beginning on March 16, 2018.